指南与共识妇科

临床环境中人乳头瘤病毒自采样检测:反思指南与临床实践脱节的契机

Self-Collection for Human Papillomavirus Testing in Clinical Settings: An Opportunity to Reflect on the Disconnect Between Guidelines and Clinical Practice.
指南 / 共识 · Obstet Gynecol · 2025-05-22

宫颈癌仍可预防,但农村、种族和少数族裔及LGBTQ+人群筛查不足。美国预防服务工作组近期草案指南提出HPV自采样筛查。临床医生采样与自采样HPV检测结果高度一致,但临床医生采样对CIN 2及以上病变的敏感性仍高于自采样。自采样目前仅获美国食品药品监督管理局批准用于医疗场所,需针对性教育、移动诊所和邮寄试剂盒等策略,并明确系统与临床层面的指南。

要点

  • 临床医生采样与自采样HPV检测结果高度一致,但临床医生采样对CIN 2及以上病变的敏感性仍高于自采样。
  • 自采样目前仅获美国食品药品监督管理局批准用于医疗场所,限制了其在服务不足地区的覆盖和效用。
  • 需针对临床医生和患者开展教育,并明确订购责任、结果通知、随访方案、标本处理和医保覆盖等指南。

核心结论

  • HPV自采样是克服传统宫颈癌预防障碍的变革性机会,但需针对性教育、明确指南和扩大批准使用范围以最大化效果。

研究设计与样本

  • 指南类文件,由美国预防服务工作组发布HPV自采样筛查宫颈癌的近期草案指南。

主要发现

  • 临床医生采样和自采样HPV检测结果高度一致。
  • 临床医生采样对CIN 2及以上病变的敏感性仍高于自采样。
  • 自采样目前仅获美国食品药品监督管理局批准用于医疗场所,限制了其在服务不足地区的覆盖和效用。

关键数值与推荐

  • 美国预防服务工作组近期草案指南提出HPV自采样用于宫颈癌筛查。
  • 自采样目前仅获美国食品药品监督管理局批准用于医疗场所。

临床怎么用

  • 在医疗场所按推荐开展HPV自采样可解决尴尬、不适和后勤限制等以患者为中心的挑战,增强可及性和参与度。
  • 针对临床医生和患者开展教育以确保正确使用。
  • 患者层面可考虑移动诊所和邮寄HPV检测试剂盒以改善可及性,尤其是对其他努力仍未覆盖的人群。
  • 系统与临床层面需明确订购责任、患者结果通知、随访方案、标本处理和每一步的医保覆盖指南。

局限性

  • 临床医生采样对CIN 2及以上病变的敏感性仍高于自采样。
  • 自采样目前仅获美国食品药品监督管理局批准用于医疗场所,限制了其在服务不足地区的覆盖和效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cervical cancer remains a preventable yet significant public health concern, particularly among rural, racial and ethnic minority, and LGBTQ+ (lesbian, gay, bisexual, transgender, queer+) populations who are more likely to be unscreened or underscreened. The recent draft guidance by the U.S. Preventive Services Task Force of human papillomavirus (HPV) self-collection for cervical cancer screening offers a transformative opportunity to overcome barriers to traditional cervical cancer prevention methods. Clinician collection and self-collection show strong agreement with HPV test results; however, clinician collection is still more sensitive than self-collection for CIN 2 or worse detection. Human papillomavirus self-collection at health care facilities, as recommended, addresses patient-centric challenges such as embarrassment, discomfort, and logistical constraints, thereby enhancing accessibility and engagement. Despite its potential, self-collection is currently approved by the U.S. Food and Drug Administration only for health care settings, limiting its reach and utility in underserved areas. To maximize the effect of self-collection, targeted educational campaigns for both clinicians and patients are essential to ensure proper utilization. At the patient level, strategies such as mobile clinics and mailed HPV testing kits could improve access, particularly among populations that, despite all other efforts, have not been reached. Clear guidelines at both the system and clinician levels regarding ordering responsibility, result notification for patients, follow-up protocols, specimen processing, and health insurance coverage at each step will be essential for successful implementation.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Mayer CM, Scarinci IC, Huh WK, et al. Self-Collection for Human Papillomavirus Testing in Clinical Settings: An Opportunity to Reflect on the Disconnect Between Guidelines and Clinical Practice. Obstet Gynecol. 2025. PMID: 40403313. doi:10.1097/AOG.0000000000005941

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。